Michael Neely, MD is an Associate Professor of Pediatrics and a Clinical Scholar at the University of Southern California (USC) in Los Angeles, CA. His research and clinical interests are in pediatric clinical pharmacometrics, including population pharmacokinetic and pharmacodynamic modeling, pharmacogenomics, simulation, and most importantly, use of models to optimize therapy for individual patients. Although Dr. Neely primarily works in the therapeutic area of infectious diseases on anti-infective compounds, he has experience with other therapeutic areas. He is currently the Director of the Laboratory of Applied Pharmacokinetics at the Children’s Hospital Los Angeles, in the USC Keck School of Medicine, working with multidisciplinary faculty collaborators in the Departments of Pediatrics, Medicine, and Preventive Medicine, as well as in the USC School of Pharmacy.
He has a Master’s of Science Degree in Clinical and Biomedical Investigations at USC, with a focus on applied Bayesian approaches to clinical trial design and pharmacokinetic modeling, is a Fellow and Regent in the American College of Clinical Pharmacology, a member of the Society for Pediatric Research, and he serves on the United States Food and Drug Administration Anti-infective Drug Advisory Committee. He is currently the principle investigator on two NIH-sponsored clinical projects involving the developmental aspects of voriconazole pharmacokinetics, as well as creating software tools to optimally dose voriconazole, vancomycin, and other therapeutic drugs. He is co-founder and part owner of Applied Pharmacometrics, Inc., maker of the BestDose software for maximally precise, Bayesian adaptive control of individual patient drug therapy. He has mentored numerous visiting scholars, has been an invited speaker worldwide, and is the author of over 60 peer-reviewed papers.